Toggle navigation
Home
Search
Services
Blog
Contact
About
Japanese Encephalitis Vaccine From Mutated Cdna Clone
Monath, Thomas P.
Acambis, Inc., Cambridge, MA, United States
Search 10 grants from Thomas Monath
Search grants from Acambis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of Vav family proteins in cell signaling and cancer
Near Infrared Diffused Light Imaging with Ultrasound
African Trypanosome Genome Sequencing
Dietary Interventions in the Elderly Trial
STTR Phase I: Controlled Phase Separation for Graphic Smart Card Display
Recently added grants:
Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis
Effect of CTHRC1 on endothelial cell survival after acute ischemia
Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PAD
Reward, impulsive sensation seeking and emotional dysregulation: neural mechanisms underlying risk for bipolar disorder in young adults
Development and Sex Differentiation of Context Fear Neural Circuits
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI036798-02
Application #
2073277
Study Section
Special Emphasis Panel (ZRG7-SSS-4 (02))
Project Start
1994-08-01
Project End
1998-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Acambis, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Related projects
NIH 1997
R44 AI
Japanese Encephalitis Vaccine From Mutated Cdna Clone
Monath, Thomas P. / Acambis, Inc.
NIH 1996
R44 AI
Japanese Encephalitis Vaccine From Mutated Cdna Clone
Monath, Thomas P. / Acambis, Inc.
Comments
Be the first to comment on Thomas Monath's grant